Crinetics Pharmaceuticals(CRNX) - 2024 Q4 - Annual Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 Form 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2024 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 f t 6055 Lusk Boulevard San Diego, California 92121 (Address of principal executive offices) (Zip code) Registrant's telephone number, including area code: (858) 450-6464 Securities registered pur ...